SCHEMBL30899264

SCHEMBL30899264

Cc1ccc(-c2nnc(-c3ccccc3)[nH]2)cc1S(=O)(=O)N1CCC(C(C)O)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.43
CNR2 P34972 2/20 0.43
POLB P06746 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 5/20 0.42
BRD4 O60885 3/20 0.41
BRD2 P25440 3/20 0.41
BRD3 Q15059 3/20 0.41
HPGD P15428 3/20 0.40
TP53 P04637 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 2/20 0.40
MAPK1 P28482 2/20 0.40
KMT2A Q03164 2/20 0.40
HSD17B10 Q99714 2/20 0.40
ALDH1A1 P00352 1/20 0.40
USP2 O75604 1/20 0.40
TSHR P16473 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27199057 0.88 CNR2 (0.48) CNR1CNR2POLBSMN1; SMN2LMNA
SCHEMBL24512148 0.86 CNR1 (0.46) CNR1CNR2POLBSMN1; SMN2LMNA
SCHEMBL29717121 0.86 CNR1 (0.46) CNR1CNR2POLBSMN1; SMN2LMNA
SCHEMBL29717201 0.84 LMNA (0.55) CNR1CNR2SMN1; SMN2LMNABRD4
SCHEMBL29717142 0.84 LMNA (0.52) CNR1CNR2SMN1; SMN2LMNABRD4
SCHEMBL30899260 0.84 CNR2 (0.44) CNR1CNR2POLBSMN1; SMN2LMNA
SCHEMBL24512122 0.84 CNR2 (0.44) CNR1CNR2POLBSMN1; SMN2LMNA
SCHEMBL29717169 0.83 BRD4 (0.54) CNR1CNR2SMN1; SMN2LMNABRD4
SCHEMBL24512245 0.81 CNR1 (0.64) CNR1CNR2SMN1; SMN2LMNABRD4
SCHEMBL29717111 0.81 CNR1 (0.64) CNR1CNR2SMN1; SMN2LMNABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117915903-A Compounds for the treatment of neurodegenerative, degenerative and metabolic disorders and uses thereof 佛罗里达大学研究基金会公司 2024-04-19 CN disclosed